![Tom Frohlich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Frohlich
Amministratore Delegato presso
JADE BIOSCIENCES, INC.
Patrimonio netto: 161 930 $ in data 31/08/2026
Profilo
Tom Frohlich was the founder of Chinook Therapeutics, Inc., founded in 2019, where the title held was Chief Operating Officer from 2021 to 2023.
Mr. Frohlich is currently Chief Executive Officer & Director at Jade Biosciences, Inc. (United States) starting in 2024 and Chief Executive Officer & Director at Jade Biosciences, Inc. starting in 2025.
Former jobs include Vice President-Business Development at Arbutus Biopharma Corp.
from 2016 to 2018, Senior Vice President-Business Development at Inception Sciences, Inc. in 2018, and Entrepreneur-in-Residence at Versant Ventures Canada Ltd. Education includes an MBA from the University of Oxford in 2007 and an undergraduate degree from the University of Victoria in 1998.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/03/2026 | 7.581 ( 0,01% ) | 161 930 $ | 31/08/2026 |
Posizioni attive di Tom Frohlich
| Società | Posizione | Inizio |
|---|---|---|
| JADE BIOSCIENCES, INC. | Amministratore Delegato | 28/04/2025 |
Precedenti posizioni note di Tom Frohlich
| Società | Posizione | Fine |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Fondatore | 01/10/2023 |
Inception Sciences, Inc.
 Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Corporate Officer/Principal | 01/12/2018 |
| ARBUTUS BIOPHARMA CORPORATION | Corporate Officer/Principal | 01/03/2018 |
Versant Ventures Canada Ltd.
 Versant Ventures Canada Ltd. Investment ManagersFinance Functions as an alternative investment manager | Investitore di Private Equity | - |
Formazione di Tom Frohlich
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Victoria
 University of Victoria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Health Technology |
Versant Ventures Canada Ltd.
Versant Ventures Canada Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
